Double-Chambered Right Ventricle (DCRV) Double Chamber Right Ventricle (DCRV) — Series: #1–2

Double-chambered right ventricle (DCRV) is an intracavitary right ventricular obstructive lesion in which anomalous hypertrophied or fibromuscular structures divide the right ventricle (RV) into a proximal high-pressure chamber and a distal low-pressure chamber. The obstruction is usually located below the pulmonary valve, within the body or subinfundibular portion of the RV, and is therefore anatomically distinct from isolated pulmonary valvar stenosis or a short segment of classical infundibular stenosis. Ventricular septal defect (VSD), particularly a perimembranous defect, is the most frequent associated lesion [1,2].

DCRV is best understood as a congenital anatomical substrate with a progressive hemodynamic phenotype. The abnormal muscle bundle may initially cause little obstruction, but serial observations have documented increasing intracavitary gradients over time [2]. More recent histopathologic work suggests that progression is not simply the result of muscle hypertrophy. In surgical specimens from patients with DCRV, turbulent flow was associated with infiltrative fibroelastic remodeling and evidence of endothelial-to-mesenchymal transition, while the degree of myocardial hypertrophy did not differ significantly from control tissue [3]. Thus, abnormal anatomy and abnormal flow appear to interact, producing progressive narrowing of the RV pathway.

1. Anatomical Concept: One Right Ventricle, Two Pressure Chambers

The defining feature is a muscular or fibromuscular partition within the RV. Proximal to the obstruction are the tricuspid valve, inlet, trabeculated body, and usually the apical RV. Distal to it are the residual outlet chamber, infundibulum, pulmonary valve, and pulmonary artery. During systole, blood must accelerate through the restricted communication between these compartments, generating a pressure drop within the ventricle itself.

The proximal chamber therefore becomes the high-pressure chamber, whereas the distal chamber is exposed to a lower systolic pressure. This distinction is clinically important because a pressure measured in the proximal RV cannot be assumed to represent pulmonary artery or pulmonary-valve pressure. In advanced disease, the proximal RV pressure may approach systemic levels despite a relatively low distal RV and pulmonary artery pressure.

Morphology varies. Classic angiographic descriptions distinguish lower obstructing bundles within the mid-RV sinus from higher subinfundibular forms, and mixed patterns occur [2]. The obstructing tissue may extend from the interventricular septum toward the RV free wall and may merge with prominent septoparietal trabeculations. The surgeon must distinguish this pathological partition from normal structures such as the septomarginal trabeculation, moderator band, papillary muscle attachments, and muscular infundibulum.

2. Relationship to Ventricular Septal Defect

VSD is not merely a coincidental association. In the classic 28-patient angiographic series, 24 patients (85%) had a VSD [2], and later surgical cohorts have similarly reported VSD in most children with DCRV. The spatial relationship between the VSD jet and the obstructing muscular substrate may contribute to progressive remodeling.

The location of the VSD relative to the obstruction also changes the physiology. If a VSD communicates with the proximal high-pressure chamber, rising proximal RV pressure reduces the LV-to-RV systolic pressure difference. Consequently, a lower VSD Doppler velocity may reflect increasing RV pressure rather than enlargement of the defect. If a VSD communicates with the distal low-pressure chamber, its shunt characteristics are different. The diagnostic map should therefore define not only VSD size and type, but also whether the defect opens proximal or distal to the intracavitary obstruction.

Associated lesions may include subaortic stenosis, aortic cusp prolapse or regurgitation, pulmonary stenosis, and less commonly other congenital abnormalities. These lesions matter because the operation is often a combined repair rather than isolated muscle resection.

3. Progressive Obstruction and Clinical Presentation

The natural history is characteristically progressive, although the rate is variable. Serial catheterization in the classic Fellows series demonstrated progression in 8 of 15 patients studied longitudinally over a mean interval of 6.6 years [2]. The mechanism is likely multifactorial: abnormal muscular geometry creates flow acceleration; turbulence and shear stress promote further muscular and fibroelastic remodeling; and the resulting narrowing further increases turbulence [3].

Children may be diagnosed during evaluation of a VSD or systolic murmur before symptoms develop. Older children and adults may present with exertional dyspnea, fatigue, exercise intolerance, chest discomfort, presyncope or syncope, or signs of right-sided pressure overload. A substantial gradient can occasionally remain clinically subtle, particularly when limitation develops gradually.

The important practical point is that mild obstruction at one time point should not automatically be considered a permanently benign finding. Follow-up should assess the trajectory of the intracavitary gradient, proximal RV pressure, RV hypertrophy and function, VSD physiology, and exercise capacity.

4. Imaging and Hemodynamic Assessment

Transthoracic echocardiography is the first-line study. The objective is to identify the actual site of intracavitary obstruction rather than simply report an “RVOT gradient.” Two-dimensional and color Doppler imaging should show the anomalous muscle bundle, the point at which flow acceleration begins, the proximal and distal chambers, and the relationship to the VSD and pulmonary valve. Continuous-wave Doppler provides peak and mean gradients, but the value remains flow-dependent and must be interpreted within the anatomical map [4].

The examination should also define pulmonary annular and valvar morphology, the main and branch pulmonary arteries, tricuspid valve function, RV hypertrophy and systolic function, and associated left-sided lesions. In adults or postoperative patients with limited acoustic windows, transesophageal echocardiography, cardiac magnetic resonance, or cardiac computed tomography can clarify the three-dimensional relationship of the obstructing tissue to the infundibulum and pulmonary valve.

Cardiac catheterization is not routinely required when noninvasive anatomy and physiology are concordant. It remains useful when Doppler and clinical findings disagree, when pulmonary vascular or shunt information is needed, or when direct pullback pressures from pulmonary artery to distal and proximal RV would clarify the level and severity of obstruction.

5. Indications and Timing of Intervention

There is no single universally accepted pediatric gradient threshold that should replace clinical judgment. Intervention is generally favored for symptoms attributable to DCRV, progressive or hemodynamically important obstruction, substantial proximal RV pressure loading, RV hypertrophy or dysfunction, or when an associated lesion already requires surgery. Because DCRV is progressive, a rising gradient may justify repair before advanced symptoms or RV dysfunction develop.

For adults, the contemporary ACC/AHA adult congenital heart disease guideline supports repair when clinically important DCRV obstruction is associated with otherwise unexplained heart-failure symptoms, cyanosis, or exercise limitation, and also supports consideration of repair in asymptomatic patients with severe obstruction to prevent adverse remodeling [5]. These recommendations are based largely on observational experience rather than randomized trials.

A mild, stable obstruction with normal RV function and no symptoms can be observed, but surveillance should be intentional. Exercise testing can be useful when the patient reports few symptoms despite a substantial gradient.

6. Surgical Strategy

Definitive treatment is surgical resection of the obstructing muscle or fibromuscular tissue. Median sternotomy, cardiopulmonary bypass, and cardioplegic arrest provide controlled exposure, particularly when a VSD or additional lesion must be repaired.

A transatrial approach through the tricuspid valve is preferred when it provides adequate visualization. It avoids an RV free-wall incision and permits simultaneous VSD closure. A complementary transpulmonary view can define the distal limit of the obstruction and confirm that the pulmonary valve and distal infundibulum are unobstructed. In a 73-patient series, 61 of 69 operated patients were repaired transatrially; only eight required an additional ventriculotomy, with no hospital or late mortality reported [6]. Earlier comparative experience also supported combined right atrial and pulmonary arterial exposure as an effective alternative to routine ventriculotomy [7].

The key technical principle is selective, incremental resection. The surgeon first identifies the true obstructing bridge or shelf, divides the dominant pathological bundle, and then removes additional hypertrophied septal or parietal tissue only as necessary to establish a smooth, adequately sized pathway. Overaggressive septal resection risks injury to conduction tissue or creation of a VSD; indiscriminate division of the septomarginal trabeculation or moderator-band complex risks right bundle branch injury and disruption of normal RV architecture. Free-wall resection must also respect papillary muscle and chordal attachments.

A limited right ventriculotomy remains useful when hypertrophy, a long or unusually oriented obstructing tunnel, prior surgery, or inadequate transatrial/transpulmonary exposure prevents safe complete resection. It should be considered an anatomy-driven exposure strategy rather than the default route.

7. VSD Closure and Patch Augmentation

After the obstructing tissue is partially resected, the VSD should be reinspected because hypertrophied muscle can obscure its true margins. A hemodynamically important VSD is generally closed during the same operation. With a perimembranous VSD, patch sutures along the posteroinferior margin must respect the expected atrioventricular conduction axis. Associated subaortic membrane, clinically important aortic valve pathology, or tricuspid valve injury should be addressed during the same procedure when indicated.

Patch augmentation is not routine for isolated DCRV. Most patients can be adequately relieved by muscle-bundle resection alone. An RVOT patch is reserved for residual fixed narrowing, a hypoplastic distal infundibulum or pulmonary annulus, associated pulmonary stenosis, or a ventriculotomy that cannot be closed without recreating obstruction. Likewise, main pulmonary artery patch augmentation should address a true MPA or supravalvar restriction or a restrictive arteriotomy closure; enlarging the MPA does not treat a mid-RV intracavitary lesion. The reconstruction should preserve pulmonary-valve geometry and avoid distortion of the branch pulmonary arteries.

8. Intraoperative Assessment

After separation from bypass, transesophageal or epicardial echocardiography should confirm relief at the original obstruction and determine whether any residual acceleration is diffuse and dynamic or represents a discrete residual shelf. Assessment should include the residual peak and mean intracavitary gradients, proximal RV pressure when available, RV systolic function, VSD patch integrity, tricuspid regurgitation, pulmonary-valve competence, and RVOT/MPA geometry.

A small residual dynamic gradient may decrease as RV hypertrophy regresses. In contrast, a focal high-velocity jet at the original partition should prompt concern for incomplete resection. Direct pressure measurement in the proximal RV, distal RV, and pulmonary artery can be particularly useful when the echocardiographic findings are equivocal.

9. Outcomes and Long-Term Surveillance

Surgical outcomes are generally excellent. In an 89-patient single-center series, the mean echocardiographic systolic gradient decreased from 66.3 mmHg preoperatively to 11.8 mmHg immediately after repair and 10.4 mmHg at longer follow-up; there were no late deaths, and reinterventions were uncommon [8]. A mixed pediatric-adult series with a median 7-year follow-up likewise reported no hospital or late deaths and no reoperation for recurrent RV obstruction [9]. In adults, transatrial, combined transatrial-transpulmonary, and selective transventricular approaches have all produced satisfactory midterm results when matched to anatomy [10].

These data are observational and derived from relatively small, heterogeneous cohorts, so they should not be interpreted as proof that recurrence or late rhythm problems never occur. Long-term surveillance should continue after repair, with attention to residual or recurrent obstruction, RV size and function, VSD patch leak, tricuspid and pulmonary valve function, aortic regurgitation when relevant, and arrhythmias.

The conceptual summary is simple: DCRV is not merely “extra RV muscle.” It is a progressive intracavitary obstructive process in which anatomy, flow, and remodeling divide the RV into two pressure chambers. Successful treatment depends on precise localization of the obstruction and conservative removal of pathological tissue while preserving normal RV structures.

For detailed morphology, see Double-Chambered Right Ventricle (DCRV) #1: Anatomy; for operative strategy, see Double-Chambered Right Ventricle (DCRV) #2: Surgical Repair.

Key Surgical and Clinical Principles

• Define the proximal and distal RV chambers and locate the exact site where flow acceleration begins.
• Map the VSD relative to the obstruction; VSD Doppler velocity may change as proximal RV pressure rises.
• Prefer transatrial exposure when adequate, adding a transpulmonary view when distal anatomy is unclear.
• Resect the pathological partition incrementally while preserving the septomarginal trabeculation, moderator band, papillary-muscle attachments, and conduction tissue.
• Close associated VSDs and address relevant subaortic, aortic-valve, pulmonary-valve, or tricuspid lesions during the same operation when appropriate.
• Do not use an RVOT or MPA patch reflexively; patch augmentation should correct a demonstrable residual fixed narrowing or associated outflow lesion.
• Verify the result with intraoperative echocardiography and, when needed, direct proximal-RV, distal-RV, and pulmonary-artery pressure measurements.

References

1. Loukas M, Housman B, Blaak C, Kralovic S, Tubbs RS, Anderson RH. Double-chambered right ventricle: a review. Cardiovasc Pathol. 2013;22(6):417-423. doi:10.1016/j.carpath.2013.03.004. PMID: 23701985.
2. Fellows KE, Martin EC, Rosenthal A. Angiocardiography of obstructing muscular bands of the right ventricle. AJR Am J Roentgenol. 1977;128(2):249-256. doi:10.2214/AJR.128.2.249. PMID: 401611.
3. Weixler V, Kramer P, Lindner J, Murin P, Cho MY, Del Nido PJ, Photiadis J, Friehs I. Endothelial-to-Mesenchymal Transition as Underlying Mechanism for the Formation of Double-Chambered Right Ventricle. Pediatr Cardiol. 2022;43(5):1084-1093. doi:10.1007/s00246-022-02828-w. PMID: 35084525.
4. Galiuto L, O’Leary PW, Seward JB. Double-chambered right ventricle: echocardiographic features. J Am Soc Echocardiogr. 1996;9(3):300-305. doi:10.1016/S0894-7317(96)90144-3. PMID: 8736014.
5. Gurvitz M, et al. 2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease. Circulation. 2026;153:e115-e251. doi:10.1161/CIR.0000000000001402. PMID: 41411375.
6. Galal O, Al-Halees Z, Solymar L, et al. Double-chambered right ventricle in 73 patients: spectrum of the disease and surgical results of transatrial repair. Can J Cardiol. 2000;16(2):167-174. PMID: 10694587.
7. Cabrera A, Martinez P, Rumoroso JR, et al. Double-chambered right ventricle. Eur Heart J. 1995;16(5):682-686. doi:10.1093/oxfordjournals.eurheartj.a060973. PMID: 7588901.
8. Surucu M, Erdoğan İ, Varan B, Özkan M, Tokel NK, Aşlamacı S. Early and late outcomes of surgical repair of double-chambered right ventricle: a single-centre experience. Cardiol Young. 2020;30(3):409-412. doi:10.1017/S1047951120000244. PMID: 32063236.
9. Telagh R, Alexi-Meskishvili V, Hetzer R, Lange PE, Berger F, Abdul-Khaliq H. Initial clinical manifestations and mid- and long-term results after surgical repair of double-chambered right ventricle in children and adults. Cardiol Young. 2008;18(3):268-274. doi:10.1017/S1047951108001984. PMID: 18312713.
10. Kottayil BP, Dharan BS, Pillai VV, Panicker VT, Gopalakrishnan SK, Jayakumar K. Surgical repair of double-chambered right ventricle in adulthood. Asian Cardiovasc Thorac Ann. 2011;19(1):57-60. doi:10.1177/0218492310395955. PMID: 21357320.